Clinical Trial Update: Avapritinib Rollover Study [Phase 4]

View source ↗

Summary

A Phase 4 rollover study of avapritinib is currently recruiting for systemic mastocytosis, sponsored by Blueprint Medicines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Mastocytosis

Drugs mentioned

• Avapritinib (avapritinib)

Snippet

Sponsor: Blueprint Medicines Corporation | Conditions: Mastocytosis, Systemic | Phase 4 | Status: RECRUITING